Adverse drug reactions and off-label and unlicensed medicines in children: A prospective cohort study of unplanned admissions to a paediatric hospital

British Journal of Clinical Pharmacology

Volumn 77, Issue 3, 2014, Pages 545-553

  Bellis, Jennifer R ^a   Kirkham, Jamie J ^b   Nunn, Anthony J ^a   Pirmohamed, Munir ^b  

^a ALDER HEY CHILDREN'S NHS FOUNDATION TRUST   (United Kingdom)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

ADR; off label; paediatric; unlicensed

Indexed keywords

ADR; OFF-LABEL; PAEDIATRIC; UNLICENSED;

ADOLESCENT; CHI-SQUARE DISTRIBUTION; CHILD; CHILD, PRESCHOOL; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; ENGLAND; FEMALE; HOSPITALS, PEDIATRIC; HUMANS; INFANT; INFANT, NEWBORN; LOGISTIC MODELS; MALE; ODDS RATIO; OFF-LABEL USE; PATIENT ADMISSION; POLYPHARMACY; PROSPECTIVE STUDIES; RISK FACTORS; TERTIARY CARE CENTERS; TIME FACTORS;

EID: 84894495350     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/bcp.12222     Document Type: Article

References (21)

1. Cuzzolin L, Atzei A, Fanos V,. Off-label and unlicensed prescribing for newborns and children in different settings: a review of the literature and a consideration about drug safety. Expert Opin Drug Saf 2006; 5: 703-718.
2. Impicciatore P, Mohn A, Chiarelli F, Pandolfini C, Bonati M,. Adverse drug reactions to off-label drugs on a paediatric ward: an Italian prospective pilot study. Paediatr Perinat Drug Ther 2002; 5: 19-24.
3. Impicciatore P, Choonara I, Clarkson A, Provasi D, Pandolfini C, Bonati M,. Incidence of adverse drug reactions in paediatric in/out-patients: a systematic review and meta-analysis of prospective studies. Br J Clin Pharmacol 2001; 52: 77-83.
4. Posthumus AAG, Alingh CCW, Zwaan CCM, van Grootheest KK, Hanff LLM, Witjes BBCM, 't Jong GW, de Hoog M,. Adverse drug reaction-related admissions in paediatrics, a prospective single-centre study. BMJ Open 2012; 2: e000934. doi: 10.1136/bmjopen-2012-00934.
5. Neubert A, Dormann H, Weiss J, Egger T, Criegee-Rieck M, Rascher W, Brune K, Hinz B,. The impact of unlicensed and off-label drug use on adverse drug reactions in paediatric patients. Drug Safety 2004; 27: 1059-1067.
6. Santos D, Clavenna A, Bonati M, Coelho H,. Off-label and unlicensed drug utilization in hospitalized children in Fortaleza, Brazil. Eur J Clin Pharmacol 2008; 64: 1111-1118.
7. Turner S, Nunn A, Fielding K, Choonara I,. Adverse drug reactions to unlicensed and off-label drugs on paediatric wards: a prospective study. Acta Paediatr 1999; 88: 965-968.
8. Horen B, Montastruc JL, Lapeyre-Mestre M,. Adverse drug reactions and off-label drug use in paediatric outpatients. Br J Clin Pharmacol 2002; 54: 665-670.
9. Kramer MS, Hutchinson TA, Flegel KM, Naimark L, Contardi R, Leduc DG,. Adverse drug reactions in general pediatric outpatients. J Pediatr 1985; 106: 305-310.
10. Gallagher RM, Mason JR, Bird KA, Kirkham JJ, Peak M, Williamson PR, Nunn AJ, Turner MA, Pirmohamed M, Smyth RL,. Adverse drug reactions causing admission to a paediatric hospital. PLoS ONE 2012; 7: e50127.
11. Gallagher RM, Kirkham JJ, Mason JR, Bird KA, Williamson PR, Nunn AJ, Turner MA, Smyth RL, Pirmohamed M,. Development and inter-rater reliability of the Liverpool adverse drug reaction causality assessment tool. PLoS ONE 2011; 6: e28096.
12. DataPharm Communications Ltd. Electronic medicines compendium. 2013. Available at http://www.medicines.org.uk/emc/ (last accessed 1 March 2013).
13. MHRA. Medicines that do not need a licence (Exemptions from licensing). 2012. Available at http://www.mhra.gov.uk/Howweregulate/Medicines/ Doesmyproductneedalicence/Medicinesthatdonotneedalicence/index.htm (last accessed 1 March 2013).
14. Paediatric Formulary Committee. BNF for Children [2008/2009]. London: BMJ Group, Pharmaceutical Press, and RCPCH Publications, 2008/2009.
15. 't Jong GW, Eland IA, Sturkenboom MCJM, van den Anker JN, Stricker BHC,. Determinants for drug prescribing to children below the minimum licensed age. Eur J Clin Pharmacol 2003; 58: 701-705.
16. Schirm E, Tobi H, de Jong-van den Berg LTW,. Risk factors for unlicensed and off-label drug use in children outside the hospital. Pediatrics 2003; 111: 291-295.
17. Mason J, Pirmohamed M, Nunn T,. Off-label and unlicensed medicine use and adverse drug reactions in children: a narrative review of the literature. Eur J Clin Pharmacol 2012; 68: 21-28.
18. van den Bemt PMLA, Egberts ACG, Lenderink AW, Verzijl JM, Simons KA, van der Pol WSCJM, Leufkens HGM,. Risk factors for the development of adverse drug events in hospitalized patients. Pharm World Sci 2000; 22: 62-66.
19. Camargo A, Cardoso Ferreira M, Heineck I,. Adverse drug reactions: a cohort study in internal medicine units at a university hospital. Eur J Clin Pharmacol 2006; 62: 143-149.
20. Davies EC, Green CF, Taylor S, Williamson PR, Mottram DR, Pirmohamed M,. Adverse drug reactions in hospital in-patients: a prospective analysis of 3695 patient-episodes. PLoS ONE 2009; 4: e4439.
21. EMA. Note for guidance on clinical investigation of medicinal products in the paediatric population (cpmp/ich/2711/99). 2009. Available at http://www.ema.europa.eu/docs/en-GB/document-library/Scientific-guideline/2009/ 09/WC500002926.pdf (last accessed 22 April 2013)